Hypera S.A. (HYPE3.SA)
BRL 16.8
(-5.46%)
BRL 16.8
(-5.46%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.71 Billion BRL | 3.44% |
| 2022 | 2.3 Billion BRL | 24.4% |
| 2021 | 1.85 Billion BRL | 37.71% |
| 2020 | 1.34 Billion BRL | -18.31% |
| 2019 | 1.64 Billion BRL | 9.51% |
| 2018 | 1.5 Billion BRL | -4.08% |
| 2017 | 1.56 Billion BRL | 13.38% |
| 2016 | 1.38 Billion BRL | 5.35% |
| 2015 | 1.31 Billion BRL | -32.69% |
| 2014 | 1.94 Billion BRL | 3.89% |
| 2013 | 1.87 Billion BRL | 24.11% |
| 2012 | 1.51 Billion BRL | -4.57% |
| 2011 | 1.58 Billion BRL | 32.53% |
| 2010 | 1.19 Billion BRL | 66.41% |
| 2009 | 717.8 Million BRL | 38.76% |
| 2008 | 517.29 Million BRL | -19.11% |
| 2007 | 639.5 Million BRL | 276.75% |
| 2006 | 169.74 Million BRL | -2.56% |
| 2005 | 174.2 Million BRL | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 510.92 Million BRL | -11.95% |
| 2024 Q2 | 644.82 Million BRL | 26.5% |
| 2023 Q3 | 630.41 Million BRL | -5.99% |
| 2023 Q1 | 551.18 Million BRL | -15.47% |
| 2023 FY | 2.38 Billion BRL | 3.44% |
| 2023 Q2 | 670.57 Million BRL | 21.66% |
| 2023 Q4 | 580.25 Million BRL | -7.96% |
| 2022 Q1 | 472.19 Million BRL | -4.09% |
| 2022 Q2 | 562.24 Million BRL | 19.07% |
| 2022 Q3 | 611.34 Million BRL | 8.73% |
| 2022 Q4 | 652.07 Million BRL | 6.66% |
| 2022 FY | 2.3 Billion BRL | 24.4% |
| 2021 Q3 | 500.04 Million BRL | 15.64% |
| 2021 FY | 1.85 Billion BRL | 37.71% |
| 2021 Q1 | 421.8 Million BRL | 8.28% |
| 2021 Q2 | 432.42 Million BRL | 2.52% |
| 2021 Q4 | 492.32 Million BRL | -1.54% |
| 2020 FY | 1.34 Billion BRL | -18.31% |
| 2020 Q2 | 276.53 Million BRL | -24.21% |
| 2020 Q1 | 364.86 Million BRL | -62.97% |
| 2020 Q4 | 389.54 Million BRL | 13.8% |
| 2020 Q3 | 342.31 Million BRL | 23.79% |
| 2019 Q4 | 985.43 Million BRL | 134.2% |
| 2019 Q1 | 357.06 Million BRL | -6.19% |
| 2019 Q3 | 420.77 Million BRL | 0.0% |
| 2019 Q2 | 420.77 Million BRL | 17.84% |
| 2019 FY | 1.64 Billion BRL | 9.51% |
| 2018 Q3 | 410.56 Million BRL | 14.31% |
| 2018 Q1 | 354.97 Million BRL | -14.48% |
| 2018 FY | 1.5 Billion BRL | -4.08% |
| 2018 Q4 | 380.64 Million BRL | -7.29% |
| 2018 Q2 | 359.15 Million BRL | 1.18% |
| 2017 Q3 | 444.01 Million BRL | 29.61% |
| 2017 Q2 | 342.57 Million BRL | -4.3% |
| 2017 Q1 | 357.96 Million BRL | -10.87% |
| 2017 FY | 1.56 Billion BRL | 13.38% |
| 2017 Q4 | 415.08 Million BRL | -6.51% |
| 2016 Q3 | 361.76 Million BRL | 15.74% |
| 2016 FY | 1.38 Billion BRL | 5.35% |
| 2016 Q4 | 401.6 Million BRL | 11.01% |
| 2016 Q2 | 312.55 Million BRL | 2.38% |
| 2016 Q1 | 305.29 Million BRL | 208.7% |
| 2015 Q2 | 531.57 Million BRL | 10.36% |
| 2015 Q3 | 565.14 Million BRL | 6.32% |
| 2015 Q4 | -280.86 Million BRL | -149.7% |
| 2015 FY | 1.31 Billion BRL | -32.69% |
| 2015 Q1 | 481.67 Million BRL | -10.86% |
| 2014 Q1 | 445.59 Million BRL | -5.58% |
| 2014 Q4 | 540.37 Million BRL | 10.93% |
| 2014 Q3 | 487.14 Million BRL | -2.06% |
| 2014 FY | 1.94 Billion BRL | 3.89% |
| 2014 Q2 | 497.39 Million BRL | 11.62% |
| 2013 Q3 | 495.97 Million BRL | 5.9% |
| 2013 Q2 | 468.33 Million BRL | 12.97% |
| 2013 Q1 | 414.56 Million BRL | 45.11% |
| 2013 FY | 1.87 Billion BRL | 24.11% |
| 2013 Q4 | 471.91 Million BRL | -4.85% |
| 2012 Q4 | 285.69 Million BRL | -31.42% |
| 2012 Q1 | 413.76 Million BRL | 10.7% |
| 2012 Q2 | 394.68 Million BRL | -4.61% |
| 2012 Q3 | 416.58 Million BRL | 5.55% |
| 2012 FY | 1.51 Billion BRL | -4.57% |
| 2011 Q4 | 373.78 Million BRL | -16.05% |
| 2011 Q1 | 375.54 Million BRL | 18.91% |
| 2011 FY | 1.58 Billion BRL | 32.53% |
| 2011 Q2 | 388.49 Million BRL | 3.45% |
| 2011 Q3 | 445.22 Million BRL | 14.6% |
| 2010 FY | 1.19 Billion BRL | 66.41% |
| 2010 Q3 | 358.23 Million BRL | 19.97% |
| 2010 Q2 | 298.6 Million BRL | 34.25% |
| 2010 Q4 | 315.83 Million BRL | -11.84% |
| 2010 Q1 | 222.42 Million BRL | -14.95% |
| 2009 Q2 | 148.51 Million BRL | 24.14% |
| 2009 Q1 | 119.63 Million BRL | 0.0% |
| 2009 FY | 717.8 Million BRL | 38.76% |
| 2009 Q4 | 261.53 Million BRL | 47.23% |
| 2009 Q3 | 177.63 Million BRL | 19.61% |
| 2008 FY | 517.29 Million BRL | -19.11% |
| 2007 FY | 639.5 Million BRL | 276.75% |
| 2006 FY | 169.74 Million BRL | -2.56% |
| 2005 FY | 174.2 Million BRL | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Blau Farmacêutica S.A. | 252.76 Million BRL | -972.264% |